Jingfeng Pharmaceutical (000908)

Overview

Hunan Jingfeng Pharmaceutical Co., Ltd., founded in 2003 and headquartered in Shanghai, China, focuses on the manufacturing and sale of chemical drugs and biological agents. The company’s operations are primarily centered in China, where it has established a significant presence in the pharmaceutical industry. Hunan Jingfeng Pharmaceutical is renowned for its dedication to the development and provision of innovative healthcare solutions, particularly through its extensive range of products and services which include orthopedics and surgery applications, ophthalmology products, Active Pharmaceutical Ingredients (APIs), and more. Additionally, the company places a strong emphasis on research and development, targeting areas such as anti-tumor, cancer, and cardiovascular drugs. This commitment is also extended to its CDMO/CMO services, showcasing its versatility and comprehensive approach in the pharmaceutical domain.

Products and Services

• Sodium Hyaluronate Injection: The flagship product of Hunan Jingfeng Pharmaceutical, this injection is primarily used in orthopedics and surgery applications, showcasing the company's expertise in product development tailored for complex medical procedures.
• Ophthalmology Products: These products are designed to address various eye health issues, reflecting the company's commitment to providing comprehensive healthcare solutions beyond their flagship offerings.
• API Products: Active Pharmaceutical Ingredients (APIs) are essential for the pharmaceutical industry. Hunan Jingfeng Pharmaceutical produces APIs that serve as the building blocks for a wide range of medications, emphasizing the company’s role in supporting broader medical and healthcare applications.
• Research and Development in Anti-Tumor, Cancer, and Cardiovascular Drugs: The company's ongoing research efforts in these critical areas indicate its dedication to tackling some of the most challenging health issues. Through focusing on the development of innovative treatments for tumor, cancer, and cardiovascular diseases, Hunan Jingfeng Pharmaceutical aims to contribute significantly to the advancement of global healthcare.
• Skin Care Products: In addition to its pharmaceutical products, the company has ventured into providing skin care products, diversifying its portfolio and meeting the growing consumer demand for dermatological health solutions.
• CDMO/CMO Services: Hunan Jingfeng Pharmaceutical extends its expertise by offering Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services. This aspect of the company’s business model demonstrates its capability and flexibility in supporting other businesses within the pharmaceutical industry, from product development through to manufacturing.